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THE FUNCTION AND RELEASE OF HMGB1
High mobility group box 1 (HMGB1), identifi ed more than 30 years ago, is a 25-kDa evolutionarily conserved and ubiquitously expressed protein. The amino sequence of HMGB1 is 98.5% identical in mammals. The major structural features of HMGB1 are its two DNA-binding domains, termed A and B box, and a negatively charged C-terminal acidic region. HMGB1 contains two nuclear-localization sequences. Most HMGB1 resides in the nucleus and functions as a non-histone chromatin-binding protein (Müller S, et al., 2001) . Early work demonstrated that HMGB1 stabilizes chromatin structure and modulates gene transcription by bending the DNA helical structure (Javaherian et al., 1978) . Another pioneering study showed that HMGB1 can be localized to cytoplasm, implicating that HMGB1 might also have important functions outside the nucleus (Bustin and Neihart, 1979) .
Twenty years later, extracellular HMGB1 was identifi ed as a proinfl ammatory cytokine and a late mediator of sepsis (Wang et al., 1999) . Unlike most classical proinfl ammatory cytokines (e.g. TNF and IL-1β) which are released early in systemic infl ammatory responses, HMGB1 is released in a delayed manner and maintains high level in the circulation after the onset of sepsis (Wang et al., 1999) . Extracellular HMGB1 initiates inflammatory responses by signaling through Toll-like receptor 4 (TLR4) (Yang et al., 2010) , and exerts chemoattractant activity by interacting with the receptor for advanced glycation end-products (RAGE) (Manfredi et al., 2008; Schiraldi et al., 2012) . In this context, fully reduced HMGB1 forms a complex with CXCL12 and greatly promotes migration of immune cells via CXCR4; whereas partially oxidized HMGB1 with a disulfi de bond between cysteine 23 and cysteine 45 triggers infl ammatory response via TLR4 Schiraldi et al., 2012) . Importantly, polyclonal or monoclonal antibodies that neutralize the proinfl ammatory activity of HMGB1 signifi cantly improve survival during lethal endotoxemia or experimental sepsis (Andersson and Tracey, 2011) . Selectively targeting HMGB1 with neutralizing antibodies also establishes that HMGB1 contributes importantly to a number of other disease syndromes, such as rheumatoid arthritis, colitis, seizures, and liver ischemia / reperfusion injury (Andersson and Tracey, 2011; Maroso and et al., 2010) . These observations position HMGB1 at the intersection between sterile injury and infectious infl ammation.
During tissue injury, HMGB1 can be passively released by damaged or necrotic cells. Cells undergoing apoptosis do not release HMGB1 at the early stage. In contrast to apoptotic cells, necrotic cells rapidly release HMGB1 and initiate sterile infl ammation in an HMGB1-dependent manner (Scaffi di et al., 2002) . During infection-induced inflammation, immune cells activated by exposure to the products of pathogenic bacteria and viruses actively release HMGB1 into the extracellular milieu (Andersson and Tracey, 2011) . Notably, extracellular ATP, a typical damage-associate molecule pattern that released by damaged or dead cells, also induces robust HMGB1 release from macrophages, suggesting that immune cells can actively release HMGB1 during sterile injury (Lamkanfi et al., 2010) . Together, these fi ndings indicate the importance to an mechanistic understanding of HMGB1 release from activated immune cells in the infl ammatory diseases.
REGULATION OF HMGB1 RELEASE BY INFLAMMASOME
Early observations indicated that pharmacological inhibition of caspase activity signifi cantly reduces HMGB1 release during endotoxemia and experimental sepsis, and significantly improves the survival of the animal. In vitro, non-specifi c caspase inhibitors block endotoxin-induced HMGB1 release from isolated macrophages. These results suggest that immune cells actively release HMGB1 in a caspases-dependent manner during infl ammation (Qin et al., 2006) .
Caspases are a group of evolutionarily conserved aspartate-specifi c cysteine proteases that cleave substrates in the onset of programmed cell death. Notably, programmed cell death is highly linked with immune defenses against pathogen infection throughout species. In highly developed organisms, the infl ammasome, an intracellular multi-protein complex, mediates caspase-1 activation, which in turn induces the maturation of pro-IL-1β and pro-IL-18, and initiates the onset of pyroptosis, a proinfl ammatory form of programmed cell death (Franchi et al., 2012; Strowig et al., 2012) . The infl ammasome also has a role as a sentinel complex in the surveillance of the intracellular environment. It consists of at least two distinct components, including pro-caspase-1, and a NOD-Like receptor (NLR) molecule or a molecule of PYHIN family . NLR molecules contain a leucine-rich-repeat (LRR) domain, which was previously thought to exert ligand-binding function. However, the molecular basis of how individual NLR molecules directly recognize their specifi c ligands is still not fully understood . PYHIN molecules, such as the absent in melanoma 2 (AIM2), are true intracellular receptors, which specifi cally recognize double-stranded DNA . Most infl ammasome protein complexes contain an adaptor protein, termed apoptosis-associated speck-like protein containing a CARD (ASC), which links pro-caspase-1 to the NLR or PYHIN molecules (Strowig et al., 2012) . Human and mouse genome encode more than 20 NLR molecules and several distinct PYHIN molecules. Among these molecules, NLRP1, NLRP3, NLRC4, and AIM2, are well-characterized inflammasome components and have been shown to assemble into functional, caspase-cleaving complexes (Franchi et al., 2012; Strowig et al., 2012) .
Recent studies reveal that the inflammasome mediates HMGB1 release from activated immune cells in response to a variety of exogenous and endogenous danger signals (Willingham et al., 2009; Lamkanfi et al., 2010) . Importantly, genetic deletion of infl ammasome components severely impairs HMGB1 release during endotoxemia or bacteriemia (Willingham et al., 2009; Lamkanfi et al., 2010) . These studies clearly indicate that the major source for HMGB1 release in sepsis and endotoxemia is subsequent to inflammasome activation. Notably, Dixit and colleagues recently discovered a noncanonical inflammasome which activates caspase-11, rather than caspase-1. Caspase-11 physically interacts with caspase-1, and contributes importantly to the maturation of pro-IL-1β and pro-IL-18, upon activation by non-canonical stimuli, such as E.coli bacteria (Kayagaki et al., 2011) . Intriguingly, caspase-11 can mediate pyroptosis and HMGB1 release in the absence of caspase-1. Genetic deletion of caspase-11 rather than caspase-1 protects mice from a lethal dose of endotoxin (Kayagaki et al., 2011) . In line with this, the loss of both IL-1β and IL-18 fails to protect mice from lethal endotoxin administration; whereas HMGB1 neutralizing antibody dose-dependently promotes survival during lethal endotoxemia (Lamkanfi et al., 2010) . These observations highlight the role of infl ammasome mediated-HMGB1 release in the pathogenesis of sepsis.
Inflammasomes mediate HMGB1 release by inducing pyroptosis (Lamkanfi et al., 2010; Lu et al., 2012 ). Previous observations demonstrate that cells undergoing apoptosis conventional programmed cell death, do not release HMGB1 at the early stage (Scaffi di et al., 2002) . In contrast to apoptosis, pyroptosis induces rapid and robust HMGB1 release (Lamkanfi et al., 2010) . Unlike necrosis, cells that undergo pyroptosis have features of DNA fragmentation, which was previously thought to be a specific signature of apoptosis (Miao et al., 2011) . Interestingly, translational modifi cations of HMGB1 can be a marker for the type of cell death that has occurred. Mass spectrometry analysis reveals that HMGB1 released via pyroptosis is hyperacetylated at the nuclear localization sequences (NLSs); whereas HMGB1 released via freeze/thaw cyclesinduced necrosis contains hypoacetylated NLSs (Lu et al., 2012) . Together with the fi nding that HMGB1 hyperacetylation at NLSs is essential for HMGB1 translocation from nucleus to cytoplasm, which facilitates subsequent HMGB1 release (Bonaldi et al., 2003; Evankovich et al., 2010) , these observations suggest that HMGB1 release from infl ammasome activation is a highly regulated process.
MINI-REVIEW
infectious agent or stimulus. Recent studies have unraveled important molecular mechanisms by which specifi c infl ammasome ligands initiate the assembly and activation of the AIM2 and NLRC4 infl ammasomes).
AIM2 consists of a Pyrin domain and a HIM domain. In the absence of ligands, these two domains within AIM2 molecule are in an autoinhibited state. AIM2 is an intracellular DNA receptor that recognizes double-stranded DNA through the HIM domain . The crystal structure of the HIM domain/DNA complex reveals that DNA recognition by AIM2 is mediated by the electrostatic attraction between the positively charged HIM domain residues and the dsDNA sugarphosphate backbone (Jin et al., 2012) . Recognition of dsDNA by the HIM domain subsequently liberates the Pyrin domain, which recruits ASC to form an infl ammasome protein complex. AIM2 and dsDNA interaction also facilitates inflammasome assembly by recruitment of multiple AIM2 molecules along the DNA staircase (Jin et al., 2012) .
The NLRC4 infl ammasome is triggered by intracellular bacterial fl agellin and the inner rod protein of the type III secretion systems of diverse bacterial species (e.g, PrgJ of Salmonella enterica serovar Typhimurium) (Franchi et al., 2012) . The NLRC4 inflammasome recognizes these structurally distinct ligands via a group of NLR families, termed apoptosis inhibitory proteins (NAIPs) (Franchi et al., 2012) . Specifi cally, NAIP5 or NAIP6 complexes with NLRC4 in response to bacterial fl agellin; whereas NAIP2 meditates the recognition of PrgJ by NAIP2-NLRC4 complex. These events are followed by the oligomerization of NLRC4 and the assembly of the NLRC4 in-
THE ROLE OF PKR IN INFLAMMASOME ACTIVATION AND HMGB1 RELEASE
New evidence links the infl ammasome, especially the NLRP3 infl ammasome, to the pathogenesis of human diseases such as obesity, type 2 diabetes, cardiovascular diseases, gout, sepsis and colitis (Strowig et al., 2012; Wen et al., 2012) . The development of therapeutics targeting the infl ammasome and HMGB1 release requires knowledge of specifi c signaling pathways that regulate inflammasome assembly and activation (Strowig et al., 2012) . The best characterized infl ammasome is the NLRP3 infl ammasome, which is triggered by exogenous and endogenous danger signals, including bacteria, RNA virus, double-stranded RNA (dsRNA), extracellular ATP, monosodium uric (MSU) acid crystal, adjuvant aluminum, and free fatty acid (Franchi et al., 2012; Strowig et al., 2012; Wen et al., 2012) . Double-stranded RNA dependent kinase (PKR) is a 65-kDa intracellular protein, which contains two RNA-binding domains at the C-terminus, and a kinase domain at the N-terminus (Dey et al., 2005) . Though it was originally identifi ed as an intracellular dsRNA receptor and a key anti-viral protein, recent studies suggest that it also functions as an intracellular stress sensing molecule. In addition to dsRNA, bacterial components and free fatty acid can induce PKR autophosphorylation (Hsu et al., 2004; Nakamura et al., 2010) . In the light of these fi ndings, we recently explored the potential role of PKR in infl ammasome activation and HMGB1 release (Lu et al., 2012) . Classical inflammasome stimuli, such as extracellular ATP, MSU, and adjuvant aluminum, induce robust PKR autophosphorylation. Genetic deletion or pharmacological inhibition of PKR significantly reduces inflammasome activation induced by various NLRP3 agonists. Overexpression of PKR significantly enhances the activity of the reconstituted NLRP3 infl ammasome in non-immune cells. PKR physically interacts with NLRP3. Importantly, PKR autophosphorylation in a cell-free system with recombinant NLRP3, ASC, and pro-caspase-1 reconstitutes inflammasome activity. These findings clearly indicate that PKR can directly regulate the NLRP3 inflammasome activation. Unexpectedly, PKR also physically interacts with other infl ammasome components, specifi cally NLRP1, NLRC4, and AIM2, which broadly regulates the activation of various types of infl ammasomes (Lu et al., 2012) .
Based on these other fi ndings, we propose that the effi cient activation of the infl ammasome requires both pattern recognition and stress-sensing (Fig. 1) .
Recognition of specifi c infl ammasome ligand
Intracellular inflammasome ligands initiate oligomerization of the NLR or PYHIN molecules and the assembly of the infl ammasome protein complex by directly or indirectly interacting with specifi c infl ammasome components (Franchi et al., 2012; Rathinam et al., 2012 ). This step is required for the infl ammasome activation, and serves as the decision-making mechanism through which the immune system determines which type of inflammasome to be activated in response to a particular fl ammasome (Kofoed and Vance., 2011; Zhao et al., 2011) .
Cellular or environmental stress sensing
Upon activation in response to cellular or environmental stress, PKR physically interacts with infl ammasome components, and is essential for the efficient activation of various inflammasomes (Lu et al., 2012) . As infl ammation can be considered to be both a tissue stress response and an adaptive response to noxious conditions (Medzhitov, 2010) , the recent identifi cation of PKR as a critical regulator of infl ammasomes has provided a novel insight into how the immune system amplifi es infl ammasome activation and adjusts the intensity of infl ammation in response to cellular or environmental stress (Lu et al., 2012) .
FUTURE PERSPECTIVE
The majority of HMGB1 is localized in the nucleus of cells in the resting state. Previous studies established that HMGB1 translocation from nucleus to cytoplasm is an esse ntial step in HMGB1 release from activated immune cells. After exposure to the infectious agents or endogenous danger signals, including LPS, bacteria, virus, and extracellular ATP, immune cells mobilize nuclear HMGB1 into cytoplasm (Lu et al., 2012; Andersson and Tracey, 2011; Lamkanfi et al., 2010) , where HMGB1 is delivered into a vesicle-like organelle, termed the secretary lysosome, as shown by electron microscope (Gardella et al., 2002) . Mechanistic studies reveal that nuclear localization of HMGB1 depends on its two nuclear localization sequences (NLSs). Acetylation of these NLSs greatly facilitates HMGB1 enrichment in the cytoplasm in both immune cells and non-immune cells (Bonaldi et al., 2003; Andersson and Tracey, 2011) . HMGB1 acetylation is regulated by both histone acetylase (HAT) and histone deacetylase (HDAC). HAT increases HMGB1 acetylation; whereas HDAC decree ase HMGB1 acetylation (Topalova et al., 2008; Evankovich et al., 2010) . During liver ischemia/reperfusion injury, the HDAC activity is significantly decreased, culminating in the hyperacetylation and nuclear translocation of HMGB1 (Evankovich et al., 2010) . Consistently, HDAC knock-down by siRNA or pharmacological inhibition of HDAC activity by Trichostatin A drastically increased HMGB1 hyperacetylation, nuclear translocation, and release, in isolated hepatocytes (Evankovich et al., 2010) . Although it is clear that immune cells release HMGB1 into the extracellular space through inflammasome-mediated pyroptosis, the mechanism of how immune cells regulate HMGB1 hyperacetylation and nuclear translocation in response to various infectious agents or endogenous danger signals remains largely unknown (Fig. 2) ; this clearly warrants investigat ion.
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